Universe Pharmaceuticals INC (UPC) — 20-F Filings

All 20-F filings from Universe Pharmaceuticals INC. Browse 2 Foreign Annual Report reports with AI-powered summaries and risk analysis.

20-F Filings (2)

Universe Pharmaceuticals Files 2024 Annual Report — Apr 29, 2025 Risk: medium
Universe Pharmaceuticals Inc. filed its annual report on Form 20-F for the fiscal year ended September 30, 2024. The company, incorporated in F4 and headquarter
Universe Pharmaceuticals INC Files Annual Report on Form 20-F — Jan 30, 2024 Risk: low
Universe Pharmaceuticals INC (UPC) filed a Foreign Annual Report (20-F) with the SEC on January 30, 2024. Universe Pharmaceuticals INC filed its annual report o

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX